Navigation Links
Edimer Pharmaceuticals and CMC Biologics Announce Agreement to Manufacture EDI200 Recombinant Protein
Date:9/9/2010

CAMBRIDGE, Mass. and BOTHELL, Wash., Sept. 9 /PRNewswire/ -- Edimer Pharmaceuticals and CMC Biologics today announce the execution of a manufacturing contract to support the development of EDI200, a clinical-stage recombinant protein for the treatment of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), a rare genetic disease with orphan designation in the USA and Europe.

(Logo:  http://photos.prnewswire.com/prnh/20100909/SF59797LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100909/SF59797LOGO)

(Logo:  http://photos.prnewswire.com/prnh/20100824/SF54816LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100824/SF54816LOGO)

CMC Biologics was selected by Edimer for their lead product due to its depth of expertise in protein development, analytical development and its cGMP manufacturing capabilities.

Neil Kirby, Ph.D., Edimer CEO, commented, "CMC's extensive experience in the GMP manufacture of therapeutic proteins makes them an ideal company to help us move this product forward. We believe that this product has the potential for making a difference in individuals' lives that currently have no available therapeutic options."

Gustavo Mahler, Ph.D., CMC Biologics Chief Operating Officer noted, "CMC is delighted to be able to assist Edimer in the development and production of this orphan protein. Our two teams are working together in an open and collaborative manner and we are excited about the project's potential."

About EDI200

Ectodysplasin-A1 (EDA-A1) is a signaling protein expressed in healthy individuals that is involved in the formation of sweat glands, teeth, hair and certain glandular struct
'/>"/>

SOURCE Edimer Pharmaceuticals; CMC Biologics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference
2. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare and Baird Global Healthcare Conferences
3. Access Pharmaceuticals Presents at American Chemical Society Annual Fall Meeting in Boston, MA
4. Xenon Pharmaceuticals Initiates a Phase 2 Clinical Trial in Post Herpetic Neuralgia (PHN) for Topical XEN402.
5. NanoSmart™ Pharmaceuticals, Inc. Receives Patent Allowance for Tumor Targeting Platform Technology
6. CORRECTED: Ampio Pharmaceuticals Announces Completion of Negotiations for Acquisition of DMI BioSciences, Inc.
7. Vanda Pharmaceuticals to Announce Second Quarter 2010 Financial Results on August 5, 2010
8. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010
9. Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients
10. Amira Pharmaceuticals Hits Two Development Milestones Related to FLAP Inhibitor Program
11. Lialda(R) - Shire Files Suit Against Cadila Healthcare Limited, Doing Business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... For an eco-friendly selection for labs and ... using metallic beads instead of water. The beads are ... germicides. Yet, the bead bath delivers exceptional temperature uniformity ... ready unlike a water bath, no warm-up time is ... eliminates the contamination and maintenance issues related to traditional ...
(Date:6/19/2013)... June 19, 2013  U.S. Secretary of State ... which distinguished Syngenta  scientist Mary-Dell Chilton , ... World Food Prize. The prize is the foremost international ... improving the quality, quantity or availability of food in ... laureates were recognized for "revolutionary biotechnology discoveries that unlocked ...
(Date:6/19/2013)... Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer ... infectious diseases, announced today that Jeffrey Riley , CEO, ... York Conference on Thursday, June 27, 2013 at The Metropolitan ... Riley is scheduled to present at 8:40 a.m. (Eastern Time). ... be accessed by logging onto the web at http://onemedplace.com/forum/webcast/ ...
(Date:6/19/2013)... CLEVELAND , June 19, 2013   NineSigma ... announced that a year following its launch, NineSights.com ... and a focal point for the worldwide community of ... to climate and environmental sustainability experts, NineSights stands out ... broad range of scientific and technical disciplines, all vetted ...
Breaking Biology Technology:Cole-Parmer Introduces Eco-Friendly Waterless Bead Baths 2Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2Synthetic Biologics to Present at OneMedForum New York 2013 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3
... Jan. 4, 2011 Advanced Life Sciences Holdings, ... a biopharmaceutical company engaged in the discovery, development and ... infection, oncology and respiratory diseases, today announced that it ... Conference held January 10-12th in San Francisco. ...
... a biological weapon so specific, it can target an individual ... seeds of death are sown into the very blueprints of ... of us, buried deep within the human genetic code. How ... diseases? Doug Flanders ponders these very questions in ...
... Jan. 4, 2011 Reportlinker.com announces ... is available in its catalogue: ... Market: DNA Probes and Biochips New ... Strategies for Instrument and Reagent Suppliers ...
Cached Biology Technology:Advanced Life Sciences to Present at the Biotech Showcase™ 2011 Conference 2James Bond Meets Cheaper by the Dozen: An Action Thriller the Entire Family Will Enjoy 2Reportlinker Adds The 2011 Molecular Diagnostics Market: DNA Probes and Biochips New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers 2
(Date:6/19/2013)... provider of scientific, technical and medical information products and ... new open access journal, GeoResJ . , ... and planetary science journals portfolio has its first open ... forum for rapid publication of top research within the ... by six Executive Editors, each covering a different discipline, ...
(Date:6/18/2013)... UT Arlington environmental engineer has been awarded a ... to ensure water quality and flow in the ... , Andrew Kruzic, UT Arlington associate professor of ... locations to add monochloramine to the water in ... new pump stations and pipelines. Adding monochloramine is ...
(Date:6/18/2013)... $12.7 million to match nine academic research groups ... explore new treatments for patients in eight disease ... schizophrenia. The collaborative pilot initiative, called Discovering New ... the National Center for Advancing Translational Sciences (NCATS) ... The process of developing a new therapeutic is ...
Breaking Biology News(10 mins):UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4
... A Century of Change, literally took 100 years to write. ... from 1906-1909. It was repeated from 1956-1958 and a technical ... anniversary of that first survey was approaching, ornithologists Mike Ward, ... of opportunity to do it again and write a book, ...
... the United States and Japan analyzed fossil evidence found ... horned dinosaur. The newly identified genus, Koreaceratops ... the late Early Cretaceous period. The specimen is ... The partial skeleton includes a significant portion of the ...
... social stress activates the immune system and accelerates the ... pressure, however, may stop this process. This is the ... Gothenburg, Sweden. Several large studies have clearly shown ... the risk of developing cardiovascular disease. However, little is ...
Cached Biology News:New book on 100 years of Illinois birds 2New book on 100 years of Illinois birds 3New book on 100 years of Illinois birds 4Scientists announce discovery of first horned dinosaur from South Korea 2Social stress leads to atherosclerosis 2
...
UltraPure DNase/RNase-Free Distilled Water is designed for use in all molecular biology applications. It is 0.1-m membrane-filtered and tested for DNase and RNase activity....
...
Water Distilled (Gibco™) is membrane filtered and endotoxin screened....
Biology Products: